Free Trial
NYSE:WAT

Waters (WAT) Stock Price, News & Analysis

Waters logo
$352.92 -0.37 (-0.10%)
Closing price 03:58 PM Eastern
Extended Trading
$353.02 +0.10 (+0.03%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Waters Stock (NYSE:WAT)

Key Stats

Today's Range
$347.44
$357.23
50-Day Range
$338.80
$366.80
52-Week Range
$292.06
$423.56
Volume
564,188 shs
Average Volume
472,883 shs
Market Capitalization
$21.00 billion
P/E Ratio
32.02
Dividend Yield
N/A
Price Target
$388.94
Consensus Rating
Moderate Buy

Company Overview

Waters Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
79th Percentile Overall Score

WAT MarketRank™: 

Waters scored higher than 79% of companies evaluated by MarketBeat, and ranked 274th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Waters has received a consensus rating of Moderate Buy. The company's average rating score is 2.61, and is based on 7 buy ratings, 9 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Waters has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Waters' stock forecast and price target.
  • Earnings Growth

    Earnings for Waters are expected to grow by 9.56% in the coming year, from $12.86 to $14.09 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Waters is 32.16, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.86.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Waters is 32.16, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.48.

  • Price to Earnings Growth Ratio

    Waters has a PEG Ratio of 3.45. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Waters has a P/B Ratio of 11.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Waters' valuation and earnings.
  • Percentage of Shares Shorted

    4.33% of the float of Waters has been sold short.
  • Short Interest Ratio / Days to Cover

    Waters has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in Waters has recently decreased by 52.26%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Waters does not currently pay a dividend.

  • Dividend Growth

    Waters does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.33% of the float of Waters has been sold short.
  • Short Interest Ratio / Days to Cover

    Waters has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in Waters has recently decreased by 52.26%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Waters has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 42 news articles for Waters this week, compared to 34 articles on an average week.
  • Search Interest

    4 people have searched for WAT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Waters to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Waters insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.63% of the stock of Waters is held by insiders.

  • Percentage Held by Institutions

    94.01% of the stock of Waters is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Waters' insider trading history.
Receive WAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Waters and its competitors with MarketBeat's FREE daily newsletter.

WAT Stock News Headlines

Republican presidential candidate former President Donald Trump speaks at a campaign rally, Saturda…
Trump administration moves to lift Biden-era mining restrictions near Boundary Waters in Minnesota
President Donald Trump’s administration is moving to lift restrictions on copper-nickel mining that the Biden administration imposed near the Boundary Waters Canoe Area Wilderness in northeastern Minnesota...
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

WAT Stock Analysis - Frequently Asked Questions

Waters' stock was trading at $370.98 at the beginning of 2025. Since then, WAT stock has decreased by 4.5% and is now trading at $354.36.

Waters Corporation (NYSE:WAT) posted its earnings results on Tuesday, May, 6th. The medical instruments supplier reported $2.25 EPS for the quarter, beating the consensus estimate of $2.22 by $0.03. The firm's revenue was up 3.9% on a year-over-year basis.
Read the conference call transcript
.

Waters subsidiaries include these companies: Andrew Alliance S.A, Andrew Alliance, Rubotherm, MPE Orbur Group Ltd. (UK), ElectroForce, Blue Reference Inc., Baehr Thermoanalyse GmbH, and more.

Top institutional investors of Waters include Assenagon Asset Management S.A. (0.07%), Swedbank AB (0.07%), Mn Services Vermogensbeheer B.V. (0.04%) and Czech National Bank (0.02%). Insiders that own company stock include Edward Conard, Christopher A Kuebler, Mark P Vergnano, Linda Baddour and Richard H Fearon.
View institutional ownership trends
.

Shares of WAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Waters investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), AU Optronics (AUOTY) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
5/06/2025
Today
7/11/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:WAT
CIK
1000697
Employees
7,600
Year Founded
1958

Price Target and Rating

High Price Target
$460.00
Low Price Target
$325.00
Potential Upside/Downside
+9.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.61
Research Coverage
18 Analysts

Profitability

EPS (Trailing Twelve Months)
$11.02
Trailing P/E Ratio
32.35
Forward P/E Ratio
27.69
P/E Growth
3.45
Net Income
$637.83 million
Net Margins
22.02%
Pretax Margin
26.24%
Return on Equity
41.70%
Return on Assets
15.67%

Debt

Debt-to-Equity Ratio
0.69
Current Ratio
1.81
Quick Ratio
1.28

Sales & Book Value

Annual Sales
$2.98 billion
Price / Sales
7.10
Cash Flow
$15.42 per share
Price / Cash Flow
23.09
Book Value
$30.80 per share
Price / Book
11.56

Miscellaneous

Outstanding Shares
59,509,000
Free Float
59,134,000
Market Cap
$21.19 billion
Optionable
Optionable
Beta
1.10

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:WAT) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners